Alzheimer’s; will an effective treatment emerge?
(Note: all the sources listed in the “Balanced” section)
Alzheimer’s disease is the main cause of dementia, memory loss,
and cognitive decline in elderly patients. The illness’ symptoms start
gradually, but worsen quickly later on, severely affecting thinking and
behavior of patients. Alzheimer’s disease remains as one of the most difficult
challenges for the biotechnology and pharmaceutical industries. Undoubtedly,
the commercial opportunity for a “disease-modifying drug therapy” for
Alzheimer’s patients has the potential to become the largest blockbuster drug
in the history of both industries. Thus far, all attempts to develop such a
candidate medicine have resulted in clinical trial failures.
